MedPath

ANAND PRASAD

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Evaluation of a Novel Method of Contrast Volume Quantification - AVERT PLUS 2.0

Completed
Conditions
Acute Kidney Injury
First Posted Date
2015-10-16
Last Posted Date
2016-06-21
Lead Sponsor
Anand Prasad
Target Recruit Count
20
Registration Number
NCT02578173

Evaluation of a Novel Method of Contrast Volume Quantification - AVERT PLUS

Terminated
Conditions
Extravasation of Contrast Media
First Posted Date
2015-05-05
Last Posted Date
2015-06-18
Lead Sponsor
Anand Prasad
Target Recruit Count
10
Registration Number
NCT02434055

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.